ESC 2022
ECpella versus ECMO in Cardiogenic Shock: Two Independent Meta-analyses
Mario Iannaccone, MD and Vasileios Panoulas, MD, discuss two meta-analyses demonstrating improved survival in cardiogenic shock managed with ECMO and Impella (ECpella™) versus ECMO alone.
HeartRecovery @ ESC 365
CAMP PCI™
CAMP was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure. Dedicated to improving interventional cardiologists patient outcomes and quality of life with supported high-risk PCI by utilizing best practices, techniques and technologies to enable safer, more effective and complete revascularization.
Protected PCI
Learn more about protected PCI.
Surgical Applications
Learn more about surgical applications for Impella® heart pumps.
AMI Cardiogenic Shock
Learn more about Impella® heart pumps and cardiogenic shock.
Right-sided Heart Failure
Learn more about Impella® RP and right-sided heart failure.
Native Heart and Lung Recovery
Conditions & Therapies
Access education, clinical evidence and practice support for Protected PCI, AMI cardiogenic shock, right heart failure, surgical applications and severe lung failure.
Products & Services
Learn about the latest technology and how that technology may best support your patient.
Education & Resources
Abiomed provides a comprehensive training program for health care providers.
NPS-2641